NCT07195448

Brief Summary

Gaining insight into how weight loss is perceived by persons with advanced cancer, and identifying potential differences related to gender and country of residence, is essential for developing comprehensive, equitable, gender-sensitive recommendations for medical nutrition therapy, with the aim of improving disease outcome.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
800

participants targeted

Target at P75+ for all trials

Timeline
6mo left

Started Feb 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress74%
Feb 2025Dec 2026

Study Start

First participant enrolled

February 10, 2025

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

September 4, 2025

Completed
22 days until next milestone

First Posted

Study publicly available on registry

September 26, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Expected
Last Updated

October 1, 2025

Status Verified

September 1, 2025

Enrollment Period

1.1 years

First QC Date

September 4, 2025

Last Update Submit

September 26, 2025

Conditions

Cancer

Outcome Measures

Primary Outcomes (1)

  • Body image

    The primary outcome measure of the GRACE study is to measure body image, by using Body Image Scale (BIS). The scoring model contains of four possible responses computing a maximum summary score of 21. The possible responses range from "not at all" (0 points) to "very much" (3 points). A higher score indicate a more distressed body image.

    2025-2027

Secondary Outcomes (1)

  • Body Image, weight loss, percent weight loss and appetite

    2025-2027

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Persons diagnosed with cancer.

You may qualify if:

  • Clinical diagnosis of cancer
  • Must be able to understand the consent form

You may not qualify if:

  • \- Expected survival time \< 3 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Karolinska Institutet

Stockholm, Sweden

RECRUITING

MeSH Terms

Conditions

Neoplasms

Central Study Contacts

Charlotte Goodrose-Flore, RDN, PhD

CONTACT

+46706442303charlotte.goodrose.flores@ki.se

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
RDN, PhD

Study Record Dates

First Submitted

September 4, 2025

First Posted

September 26, 2025

Study Start

February 10, 2025

Primary Completion

April 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

October 1, 2025

Record last verified: 2025-09

Locations

SE(1)